Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999333 · ClinicalTrials.gov registry record · NA
Virtual Reality in SOD
A NA study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03999333 is a NA study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 16 participants.
The verdict
NCT03999333, a NA study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Patients with classic type-3 Sphincter of Oddi dysfunction have chronic debilitating pain not amenable to pharmacologic or endoscopic therapy. Previous studies have shown benefits of virtual reality (VR) for pain management through immersive three-dimensional (3D) multisensory experiences, but only in short-term inpatient settings. The impact of VR for chronic pain in patients with SOD III in an outpatient setting is being evaluated in this pilot study.
Interventions
- DEVICE Virtual Reality (Oculus Go)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-08-21 |
| Est. Completion | 2025-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03999333
The ClinicalTrials.gov registry entry for NCT03999333 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality (Oculus Go) is the first listed.
NCT03999333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03999333 about?
NCT03999333 is a clinical study titled "Virtual Reality in SOD". Patients with classic type-3 Sphincter of Oddi dysfunction have chronic debilitating pain not amenable to pharmacologic or endoscopic therapy. Previous studies have shown benefits of virtual reality (VR) for pain management through immersive three-dimensional (3D) multisensory experiences, but only ...
What is the current status of trial NCT03999333?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2019-08-21. Estimated completion is 2025-02-10.
What interventions are being tested in trial NCT03999333?
The interventions under investigation include: Virtual Reality (Oculus Go) (DEVICE).
Who is sponsoring clinical trial NCT03999333?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.